Health vulnerabilities in female sex workers in Brazil, 2016.

Female sex workers (FSW) suffer stigma and discrimination that negatively impact their physical and mental health and affect access to health care services. This paper aims to describe selected health indicators among FSW in 12 Brazilian cities in 2016. Brazilian cross-sectional Biological Behavioral Surveillance Survey was conducted in 2016 among 4328 FSW recruited by respondent-driven sampling. The sample weighing was inversely proportional to participant's network sizes and the seeds were excluded from the analysis. Health indicators were estimated with 95% confidence interval and included indicators of health status, symptoms of depression, antenatal care, pap smear coverage, signs and symptoms of sexually transmitted infection, contraception and regular condom use, number of births and children alive per women, human immunodeficiency virus and syphilis testing, usual source of care, and perception of discrimination. Most participants self-rated their health as very good/good (65.8%) and 27.7% were positively screened for major depressive disorder episode on Patient Health Questionnaire-2. Antenatal coverage was 85.8% and 62.3% of FSW had access to pap smear exam in the past 3 years. A total of 67.0% of FSW were using some contraceptive method at the time of the study. Male condom was the most common method (37.1%), followed by oral pill (28.9%). A total of 22.5% FSW had never been tested for HIV and the main reasons were "not feeling at risk" (40.4%) and "being afraid or ashamed" (34.0%). The vast majority of FSW used Brazilian National Health System as their usual source of health care (90.2%). Approximately one-fifth of the participants felt discriminated against or were treated worse for being FSW (21.4%) and only 24.3% disclose their sex work status in health services. The vulnerability of FSW is expressed in all health indicators. Indicators of health status, antenatal care, pap smear coverage, and contraception were worse than in the Brazilian population, and point out to the importance of increase FSW's access to health care services. Also, stigma and discrimination emerged as an important barrier to FSW's health care in all dimensions and need to be struggled.

Metabolic comorbidities and systemic arterial hypertension: the challenge faced by HIV patients on long-term use of antiretroviral therapy.

OBJECTIVE: Our objective was to estimate the frequency of comorbidities and assess its relationship with exposure factors after long-term ART use. METHODS: A cross-sectional study with PLHIV (≥18 years-old), who initiated ART between 2001 and 2005 and attended an HIV/AIDS public referral center (Belo Horizonte/Brazil), was performed. Demographic, clinical, therapeutic, and lifestyle data were obtained through interviews, medical charts, public database, routine laboratory examinations, and bone densitometry. The outcome was the number of comorbidities: hyperglycemia, dyslipidemia, systemic arterial hypertension (SAH), and low bone mineral density (BMD). Absolute/relative frequencies were calculated. Factors associated with the outcome were assessed by quasi-Poisson regression. RESULTS: Of the 98 participants, 53% were male and 79% and over 43 years-old. Moderate physical activity was observed in 82%, overweight/obesity in 50%, and 58% used ART based on two nucleoside reverse transcriptase inhibitors (NRTIs) plus one non-nucleoside reverse transcriptase inhibitor (NNRTI). After a mean of 15.6 years of ART exposure, 207 comorbidities were identified and 93% participants presented at least one comorbidity (mean = 2.1/participant). The most frequent overlapping constituted two co-occurrences: dyslipidemia + hyperglycemia or dyslipidemia + SAH, n = 36 for each co-occurrence. The quasi-Poisson regression showed an increase of 3% in the number of comorbidities per year of age (OR = 1.03; 95%CI = 1.02-1.04) and 84% among PLHIV on moderate physical activity (ref = heavy physical-activity) (OR = 1.84; 95%CI = 1.08-3.13). CONCLUSIONS: Our study shows that the aging slightly contributed to comorbidities. However, the practice of physical-activities is crucial to prevent chronic-diseases. Treatment and preventive measures should be encouraged to diminish the burden of disease and improve quality of life among PLHIV.

Sexual, reproductive health and health status of female sex workers in 12 Brazilian cities, 2016.

OBJECTIVE: To investigate differences in sexual, reproductive health and health status indicators of female sex workers in 12 Brazilian cities. METHODS: Cross-sectional study of biological and behavioral surveillance survey with a minimum sample of 350 female sex workers per city, recruited by respondent driven sampling, in 2016. Complex sample design was considered in the data analysis. Indicators and 95% confidence intervals related to sexual and reproductive health, and health status were described separately by city and for the total sample. RESULTS: The total sample consisted of 4,328 female sex workers. The coverage of Pap smear exam, human immunodeficiency virus and syphilis tests and antenatal care indicators varied by 20 percentages points or more. Pap smear exam coverage ranged from 53.4% in Recife to 73.0% in Porto Alegre. The highest percentage of female sex workers who had never been tested for human immunodeficiency virus and syphilis was in Fortaleza (36.8 and 63.8%, respectively). Antenatal coverage ranged from 61.1% in Salvador to 99.0% in Curitiba. In five cities, the proportion of female sex workers who disclosed their sex work status in health services was over 20.0%. CONCLUSION: The differences between the indicators in the 12 cities followed the Brazilian population profile, with more vulnerable sex workers in the North and Northeast regions. The results show that it is essential to consider the barriers to accessing health, such as stigma and discrimination, which restrict the addressing of female sex workers specific needs.

Sexual, reproductive health and health status of female sex workers in 12 Brazilian cities, 2016 / Saúde sexual, reprodutiva e estado de saúde de mulheres trabalhadoras do sexo em 12 cidades brasileiras, 2016

ABSTRACT: Objective: To investigate differences in sexual, reproductive health and health status indicators of female sex workers in 12 Brazilian cities. Methods: Cross-sectional study of biological and behavioral surveillance survey with a minimum sample of 350 female sex workers per city, recruited by respondent driven sampling, in 2016. Complex sample design was considered in the data analysis. Indicators and 95% confidence intervals related to sexual and reproductive health, and health status were described separately by city and for the total sample. Results: The total sample consisted of 4,328 female sex workers. The coverage of Pap smear exam, human immunodeficiency virus and syphilis tests and antenatal care indicators varied by 20 percentages points or more. Pap smear exam coverage ranged from 53.4% in Recife to 73.0% in Porto Alegre. The highest percentage of female sex workers who had never been tested for human immunodeficiency virus and syphilis was in Fortaleza (36.8 and 63.8%, respectively). Antenatal coverage ranged from 61.1% in Salvador to 99.0% in Curitiba. In five cities, the proportion of female sex workers who disclosed their sex work status in health services was over 20.0%. Conclusion: The differences between the indicators in the 12 cities followed the Brazilian population profile, with more vulnerable sex workers in the North and Northeast regions. The results show that it is essential to consider the barriers to accessing health, such as stigma and discrimination, which restrict the addressing of female sex workers specific needs.

RESUMO: Objetivo: Investigar diferenças nos indicadores de saúde sexual, reprodutiva e de estado de saúde de mulheres trabalhadoras do sexo em 12 cidades brasileiras. Métodos: Estudo de corte transversal comportamental e biológico, com amostra mínima de 350 mulheres trabalhadoras do sexo por cidade, recrutadas por Respondent-Driven Samplig, em 2016. Na análise de dados, foi considerado o desenho complexo de amostragem. Foram apresentados indicadores e respectivos intervalos de 95% de confiança relacionados à saúde sexual, reprodutiva e ao estado de saúde separadamente por cidade e para a amostra total. Resultados: A amostra total foi de 4.328 mulheres trabalhadoras do sexo. A cobertura de exame de Papanicolau e teste para vírus da imunodeficiência humana e sífilis, e os indicadores de pré-natal apresentaram variação igual ou superior a 20 pontos percentuais. A cobertura de exame de Papanicolau variou de 53,4%, em Recife, a 73%, em Porto Alegre. O maior percentual de mulheres trabalhadoras do sexo que nunca realizaram o teste para vírus da imunodeficiência humana e sífilis foi registrado em Fortaleza (36,8 e 63,8%, respectivamente). A cobertura de pré-natal variou de 61,1%, em Salvador, a 99%, em Curitiba. Em cinco cidades, o percentual de participantes que afirmou já ter sentido discriminação no serviço de saúde por ser trabalhadora do sexo foi superior a 20%. Conclusões: As diferenças entre os indicadores nas 12 cidades acompanharam o perfil da população brasileira, com mulheres trabalhadoras do sexo mais vulneráveis nas regiões Norte e Nordeste. Os resultados mostram que é fundamental considerar as barreiras de acesso à saúde, como o estigma e a discriminação, que impedem a contemplação das necessidades específicas dessas mulheres.

Monitoring HIV infection in Minas Gerais state: 15-year assessment of adults living with HIV initiating Antiretroviral Therapy.

INTRODUCTION: The first Brazilian HIV treatment recommendation was put forward in 1996, resulting in 12 subsequent guidelines. Several changes were made regarding "when" and "how" to begin treatment. The latest guideline recommends immediate initiation of antiretroviral therapy (ART). This study aimed to describe the evolution of HIV treatment among people living with HIV (PLHIV) who initiated ART between 2004 and 2018 based on the national guideline recommendations concerning T-CD4+ and VL measurements. METHODS: A cross-sectional analysis of data of PLHIV aged >18 years, in Minas Gerais who received ART between 2004 and 2018 was conducted. Clinical, therapeutic, and demographic information were obtained from national healthcare databases. The study was divided into four periods: 2004-2007, 2008-2012, 2013-2016, and 2017-2018. Descriptive analyses were performed. RESULTS: A total of 60,618 PLHIV initiated ART (67% male and 48% aged 25-39 years), 36% of whom had CD4 counts at ART initiation and 51% documented VL after ART initiation. The median CD4 count ranged from 288 to 373 cells/µL. The median time to ART initiation decreased from 604 to 28 days and was lower among males (p <0.01). The median time from ART initiation to the first VL result decreased from 101 to 62 days over the study period, while the median VL after ART initiation ranged from 2.3 to 1.7 log10 copies/ml. CONCLUSIONS: Although our results demonstrated that most recommendations were followed, there seemed to be little impact on CD4 counts and VL testing. This may result in an inadequate evaluation of ART effectiveness.

Characterization of female sex workers in Brazilian state capitals, 2016. / Caracterização de mulheres trabalhadoras do sexo em capitais brasileiras, 2016.

Objective To describe the characteristics of female sex workers (FSW) in 12 Brazilian cities. Methods This was a cross-sectional biological and behavioral surveillance study with FSW recruited by respondent-driven sampling (RDS) in 2016. HIV prevalence, sociodemographic, behavioral and sex work profession variables were estimated by city. The chi-square test was used to compare these distributions. Results Among 4,328 FSW, HIV prevalence was 5.3% (95%CI 4.5;6.3), ranging from 0.2% (95% CI 0.0;1.2), in Campo Grande, to 18.2 (95%CI 13.2;24.7) in Salvador. In half of the cities, HIV prevalence in the samples was >5.0%, while Campo Grande, Brasília and Belo Horizonte had prevalence rates <1.0%. Significant differences between cities were found in distributions according to educational level, income, workplace, age sex work started, and illicit drug use. Conclusion The characteristics of the samples in each city were distinct and have influenced local HIV prevalence.

Caracterização de mulheres trabalhadoras do sexo em capitais brasileiras, 2016 / Caracterización de las mujeres trabajadoras sexuales en las capitales brasileñas, 2016 / Characterization of female sex workers in Brazilian state capitals, 2016

Objetivo: Descrever as características das mulheres trabalhadoras do sexo (MTS) de 12 capitais brasileiras. Métodos: Estudo transversal de vigilância biológica e comportamental com MTS recrutadas por respondent-driven sampling (RDS), em 2016. Foram estimadas, por cidade, as prevalências de HIV, características sociodemográficas, comportamentais e da profissão. Utilizou-se o teste do Qui-Quadrado para comparar essas distribuições. Resultados: Entre 4.328 MTS, a prevalência da infecção pelo HIV foi de 5,3% (IC95% 4,5;6,3), variando de 0,2% (IC95% 0,0;1,2), em Campo Grande, a 18,2% (IC95%13,2;24,7) em Salvador. Em metade das cidades, a prevalência de HIV nas amostras foi >5,0%, enquanto Campo Grande, Brasília e Belo Horizonte apresentaram prevalências <1,0%. Diferenças significativas entre as cidades foram encontradas nas distribuições segundo escolaridade, renda, local de trabalho, idade de início do trabalho sexual, e uso de drogas ilícitas. Conclusão: As características das amostras em cada cidade foram distintas, e influenciaram a prevalência local de HIV.

Objetivos: Describir las características de las mujeres trabajadoras sexuales (MTS) de 12 ciudades brasileñas. Métodos: Estudio transversal de vigilancia biológica y conductual con MTS reclutadas por Respondent-Driven Sampling (RDS) 2016. La prevalencia del VIH, las características sociodemográficas, de comportamiento y relacionadas con la profesión se estimaron por ciudad. Se utilizó la prueba de Chi cuadrado para comparar esas distribuciones. Resultados: Entre 4,328 MTS, la prevalencia del VIH fue 5,3% (IC95%4,5; 6,3), variando de 0,2% (IC95% 0,0;1,2) en Campo Grande a 18,2% (IC95% 13,2; 24,7) en Salvador. En la mitad de las ciudades, la prevalencia del VIH fue >5,0%, mientras que Campo Grande, Brasíla y Belo Horizonte tuvieron prevalencia de, <1,0%. Se encontraron diferencias significativas entre las ciudades en las distribuciones, de acuerdo con la escolaridad, ingresos, lugar de trabajo, edad de inicio del trabajo sexual y uso de drogas ilícitas. Conclusión: Las características de las muestras locales fueron diferentes e influyeron en la prevalencia local del VIH.

Objective: To describe the characteristics of female sex workers (FSW) in 12 Brazilian cities. Methods: This was a cross-sectional biological and behavioral surveillance study with FSW recruited by respondent-driven sampling (RDS) in 2016. HIV prevalence, sociodemographic, behavioral and sex work profession variables were estimated by city. The chi-square test was used to compare these distributions. Results: Among 4,328 FSW, HIV prevalence was 5.3% (95%CI 4.5;6.3), ranging from 0.2% (95% CI 0.0;1.2), in Campo Grande, to 18.2 (95%CI 13.2;24.7) in Salvador. In half of the cities, HIV prevalence in the samples was >5.0%, while Campo Grande, Brasília and Belo Horizonte had prevalence rates <1.0%. Significant differences between cities were found in distributions according to educational level, income, workplace, age sex work started, and illicit drug use. Conclusion: The characteristics of the samples in each city were distinct and have influenced local HIV prevalence.

Monitoring HIV infection in Minas Gerais state: 15-year assessment of adults living with HIV initiating Antiretroviral Therapy

Abstract INTRODUCTION The first Brazilian HIV treatment recommendation was put forward in 1996, resulting in 12 subsequent guidelines. Several changes were made regarding "when" and "how" to begin treatment. The latest guideline recommends immediate initiation of antiretroviral therapy (ART). This study aimed to describe the evolution of HIV treatment among people living with HIV (PLHIV) who initiated ART between 2004 and 2018 based on the national guideline recommendations concerning T-CD4+ and VL measurements. METHODS A cross-sectional analysis of data of PLHIV aged >18 years, in Minas Gerais who received ART between 2004 and 2018 was conducted. Clinical, therapeutic, and demographic information were obtained from national healthcare databases. The study was divided into four periods: 2004-2007, 2008-2012, 2013-2016, and 2017-2018. Descriptive analyses were performed. RESULTS A total of 60,618 PLHIV initiated ART (67% male and 48% aged 25-39 years), 36% of whom had CD4 counts at ART initiation and 51% documented VL after ART initiation. The median CD4 count ranged from 288 to 373 cells/µL. The median time to ART initiation decreased from 604 to 28 days and was lower among males (p <0.01). The median time from ART initiation to the first VL result decreased from 101 to 62 days over the study period, while the median VL after ART initiation ranged from 2.3 to 1.7 log10 copies/ml. CONCLUSIONS Although our results demonstrated that most recommendations were followed, there seemed to be little impact on CD4 counts and VL testing. This may result in an inadequate evaluation of ART effectiveness.

Effectiveness of second-line antiretroviral therapy: the impact of drug switches.

Including antiretroviral drug switches as a measure of ART failure could be more suitable than conventional measures to evaluate health outcomes in "real-world" settings. This is part of a historical cohort of HIV-infected adults who initiated ART from 2001-2005, and were followed up for a maximum of five years in three HIV/AIDS centers in Belo Horizonte, Brazil. Follow-up information included data from 2001-2010. All patients switched from first-line ART were included. Second-line ART effectiveness was measured as the time-to-ART failure. Failure was defined simulating two scenarios: (1) Clinical, immunological and virological failure (scenario 1); and scenario 1 plus ART switches (scenario 2). Descriptive analysis, Kaplan-Meier curves, log-rank test, and Cox proportional hazards model were performed. We identified 119 eligible patients; most had protease inhibitor (PI)-based regimens prescribed as second-line. The incidence of failure was different for the two scenarios (29.4% vs. 54.6% for scenario 1 and 2, respectively; p < 0.001). The main identifiers of failure were increase in viral load (31.1%) for scenario 1 and ART switches (42.8%) for scenario 2. Median duration on second-line ART was 36.8 vs. 19.8 months for scenario 1 and 2, respectively. In the Cox analysis of scenario 2, increased risk was found for patients given PI-based second-line regimens (HR = 2.26; 95% CI: 1.09-3.17). There is a high incidence of ART failure associated with PI-based regimens when ART switches are considered as an indicator of failure. This demonstrates the impact of ART switches in representing lack of ART effectiveness.

Adverse reactions to antiretroviral therapy: a prevalent concern.

The risk-benefit ratio of antiretroviral therapy (ART) is usually considered favorable due to the urgent need to control the HIV/AIDS epidemic. Current studies have shown that combined ART (two or more drugs, from two different classes) is the most effective, with benefits that go beyond clinical management of the disease playing a crucial role in preventing HIV transmission. Therefore, early identification of HIV infection followed by immediate initiation of ART has been encouraged worldwide. However, the success of this strategy has been threatened by poor engagement of patients in HIV care, which may be related to drug harms. In addition, ART is required for the life course, creating the potential for adverse drug reactions (e.g., lipodystrophies). Therefore, adverse drug reactions are a prevalent concern among people living with HIV/AIDS, even in the current era of early initiation of ART ("early ART"), with most drugs considered much safer than those used in previous eras. Accurate diagnosis, recording, and reporting, followed up with proper management and prevention, and intensive surveillance, of new and known adverse reactions to ART, should be strongly encouraged as part of the care continuum.

La relación entre los riesgos y beneficios del tratamiento antirretroviral (TAR) generalmente se considera favorable debido a la urgente necesidad de controlar la epidemia de VIH/SIDA. Los estudios actuales han revelado que la politerapia antirretrovírica (dos o más medicamentos de dos clases diferentes) es la más eficaz porque no solo trata la enfermedad, sino que tiene una función crucial como método preventivo de la transmisión del VIH. Por consiguiente, en todo el mundo se ha promovido el diagnóstico temprano de la infección por el VIH seguido del inicio inmediato del TAR. Sin embargo, la efectividad de esta estrategia ha sido comprometida por la baja retención de pacientes en los servicios de salud, que puede estar asociada a seguridad en el uso de los medicamentos. Además, dado que estos pacientes deben recibir TAR durante toda la vida, aumenta la probabilidad de que presenten reacciones adversas a los medicamentos (por ejemplo, lipodistrofias). De esta forma, las reacciones adversas a los antirretrovirales se tornaron una constante preocupación, incluso en la era actual de inicio precoz de la TAR, en que los medicamentos son considerados más seguros que aquellos utilizados en el pasado. El diagnóstico preciso, registro y notificación de las reacciones adversas, seguidos de manejo y prevención adecuados, y vigilancia intensiva para detectar reacciones adversas (nuevas y conocidas) deben ser fuertemente recomendadas como parte de la cascada del cuidado continuado.

A relação risco-benefício da terapia antirretroviral (TARV) é considerada favorável devido à urgente necessidade de controlar a epidemia de HIV/aids. Estudos recentes demonstram que a TARV combinada (dois ou mais medicamentos de duas classes distintas) é altamente efetiva, apresentando benefícios que ultrapassam o objetivo do manejo clínico da doença, pois contribui de forma significativa para a prevenção da transmissão do HIV. Recomenda-se, portanto, o diagnóstico precoce da infecção pelo HIV e o início imediato da TARV em todo o mundo. Todavia, a efetividade dessa estratégia tem sido comprometida pela baixa retenção de pacientes nos serviços de saúde, que pode estar associada à segurança no uso dos medicamentos. Além disso, o uso da TARV se faz necessário por toda a vida, o que possibilita a ocorrência de reações adversas (como lipodistrofias). Dessa forma, as reações adversas aos antirretrovirais se tornaram uma constante preocupação, mesmo na era atual de início precoce da TARV, em que os medicamentos são considerados mais seguros do que aqueles utilizados no passado. O diagnóstico preciso, o registro e a notificação das reações adversas, acompanhados de tratamento e prevenção adequados, além de intensiva vigilância para detecção de reações adversas (novas e conhecidas) devem ser fortemente recomendadas como parte da cascata do cuidado contínuo.

Adverse reactions to antiretroviral therapy: a prevalent concern / Las reacciones adversas al tratamiento antirretroviral: una preocupación frecuente / Reações adversas à terapia antirretroviral: uma preocupação frequente

ABSTRACT The risk-benefit ratio of antiretroviral therapy (ART) is usually considered favorable due to the urgent need to control the HIV/AIDS epidemic. Current studies have shown that combined ART (two or more drugs, from two different classes) is the most effective, with benefits that go beyond clinical management of the disease playing a crucial role in preventing HIV transmission. Therefore, early identification of HIV infection followed by immediate initiation of ART has been encouraged worldwide. However, the success of this strategy has been threatened by poor engagement of patients in HIV care, which may be related to drug harms. In addition, ART is required for the life course, creating the potential for adverse drug reactions (e.g., lipodystrophies). Therefore, adverse drug reactions are a prevalent concern among people living with HIV/AIDS, even in the current era of early initiation of ART ("early ART"), with most drugs considered much safer than those used in previous eras. Accurate diagnosis, recording, and reporting, followed up with proper management and prevention, and intensive surveillance, of new and known adverse reactions to ART, should be strongly encouraged as part of the care continuum.

RESUMEN La relación entre los riesgos y beneficios del tratamiento antirretroviral (TAR) generalmente se considera favorable debido a la urgente necesidad de controlar la epidemia de VIH/SIDA. Los estudios actuales han revelado que la politerapia antirretrovírica (dos o más medicamentos de dos clases diferentes) es la más eficaz porque no solo trata la enfermedad, sino que tiene una función crucial como método preventivo de la transmisión del VIH. Por consiguiente, en todo el mundo se ha promovido el diagnóstico temprano de la infección por el VIH seguido del inicio inmediato del TAR. Sin embargo, la efectividad de esta estrategia ha sido comprometida por la baja retención de pacientes en los servicios de salud, que puede estar asociada a seguridad en el uso de los medicamentos. Además, dado que estos pacientes deben recibir TAR durante toda la vida, aumenta la probabilidad de que presenten reacciones adversas a los medicamentos (por ejemplo, lipodistrofias). De esta forma, las reacciones adversas a los antirretrovirales se tornaron una constante preocupación, incluso en la era actual de inicio precoz de la TAR, en que los medicamentos son considerados más seguros que aquellos utilizados en el pasado. El diagnóstico preciso, registro y notificación de las reacciones adversas, seguidos de manejo y prevención adecuados, y vigilancia intensiva para detectar reacciones adversas (nuevas y conocidas) deben ser fuertemente recomendadas como parte de la cascada del cuidado continuado.

RESUMO A relação risco-benefício da terapia antirretroviral (TARV) é considerada favorável devido à urgente necessidade de controlar a epidemia de HIV/aids. Estudos recentes demonstram que a TARV combinada (dois ou mais medicamentos de duas classes distintas) é altamente efetiva, apresentando benefícios que ultrapassam o objetivo do manejo clínico da doença, pois contribui de forma significativa para a prevenção da transmissão do HIV. Recomenda-se, portanto, o diagnóstico precoce da infecção pelo HIV e o início imediato da TARV em todo o mundo. Todavia, a efetividade dessa estratégia tem sido comprometida pela baixa retenção de pacientes nos serviços de saúde, que pode estar associada à segurança no uso dos medicamentos. Além disso, o uso da TARV se faz necessário por toda a vida, o que possibilita a ocorrência de reações adversas (como lipodistrofias). Dessa forma, as reações adversas aos antirretrovirais se tornaram uma constante preocupação, mesmo na era atual de início precoce da TARV, em que os medicamentos são considerados mais seguros do que aqueles utilizados no passado. O diagnóstico preciso, o registro e a notificação das reações adversas, acompanhados de tratamento e prevenção adequados, além de intensiva vigilância para detecção de reações adversas (novas e conhecidas) devem ser fortemente recomendadas como parte da cascata do cuidado contínuo.